Leukemia & Lymphoma
Volume 64, 2023 - Issue 2
Open access
1,906
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study
Hareth Nahia Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, SwedenCorrespondence[email protected]
View further author information
, View further author information
Saad Z. Usmanib Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
, Maria-Victoria Mateosc University Hospital of Salamanca/IBSAL/Cancer Research Center – IBMCC (USAL-CSIC), Salamanca, Spain
https://orcid.org/0000-0003-2390-1218View further author information
Niels W. C. J. van de Donkd Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The NetherlandsView further author information
, Albert Oriole Institut Català d‘Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, SpainView further author information
, Torben Plesnerf Vejle Hospital and University of Southern Denmark, Vejle, DenmarkView further author information
, Nibedita Bandyopadhyayg Janssen Research & Development, LLC, Spring House, PA, USAView further author information
, Peter Hellemansh Janssen Research & Development, Beerse, BelgiumView further author information
, Brenda Trompi Janssen Research & Development, LLC, Leiden, The NetherlandsView further author information
, Ivo Nnaneg Janssen Research & Development, LLC, Spring House, PA, USAView further author information
, Donna Zemlickisj Janssen Research & Development, LLC, Toronto, Ontario, CanadaView further author information
, Ajai Charik Icahn School of Medicine at Mount Sinai, New York, NY, USA
https://orcid.org/0000-0002-0405-7480View further author information
Philippe Moreaul Hematology Department, University Hospital Hôtel-Dieu, Nantes, FranceView further author information
show all
Pages 468-472
|
Received 15 Jul 2022, Accepted 05 Nov 2022, Published online: 02 Jan 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.